Qureight
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
$20MSeries B
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
End-to-end imaging company for clinical trials with a focus on lung and heart disease.
Building the sovereign infrastructure layer for high-consequence operations and AI-driven systems
Develops commercial fusion power plants based on stellarator concept
Develops quantum compression technology to enable computation on existing quantum and classical systems
Produces TRISO nuclear fuel for advanced nuclear reactors
Pitching XTX Ventures? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room